Hasija Amit bought MIST
December 12, 2025 · Form 4 insider transaction
Hasija Amit bought 100,000 shares of Milestone Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 47 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
N/A
Total value
N/A
InsiderHasija Amit
RoleOfficer
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateJanuary 28, 2026
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a performance stock unit ("PSU") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil).; Each PSU represents a contingent right to receive one common share.